Timothy Piatkowski, a senior research fellow at the University of Queenslands Centre for Health Services Research specialising in performance enhancing drugs (who has himself dabbled with products like BPC-157 in the past) says that such synthetic peptides have been popular in bodybuilding circles for more than a decade
and (3) direct comparison of SGLT2i and GLP1-ra therapies demonstrated that the GLP1-ra cohort had an increased risk for the development of both diabetic retinopathy and DMO
Common risk factors included female sex, family history, stress, poor sleep, menstruation, noise, sunlight, and dietary triggers
Its one of the newest medications for type 2 diabetes and weight loss
This is particularly beneficial for those dealing with obesity, as it aids in weight loss